共 22 条
[1]
ASBELL B, 1995, PILL BIOGRAPHY DRUG, P19
[2]
Calle EE, 1996, LANCET, V347, P1713, DOI 10.1016/S0140-6736(96)90806-5
[3]
*CDC NAT I CHILD H, 1987, NEW ENGL J MED, V316, P650
[4]
FARLEY TMM, 1995, LANCET, V346, P1582
[5]
Farmer R. D. T., 1995, Journal of Obstetrics and Gynaecology (Abingdon), V15, P195, DOI 10.3109/01443619509015499
[6]
*GALL ORG, 1994, WOM ATT OR CONTR OTH
[7]
Hatcher RA, 1998, CONTRACEPTIVE TECHNO, P405
[8]
RISK OF IDIOPATHIC CARDIOVASCULAR DEATH AND NONFATAL VENOUS THROMBOEMBOLISM IN WOMEN USING ORAL-CONTRACEPTIVES WITH DIFFERING PROGESTAGEN COMPONENTS
[J].
LANCET,
1995, 346 (8990)
:1589-1593
[10]
Killick S. R., 1992, Advances in Contraception, V8, P57, DOI 10.1007/BF01849451